1Funder JW. Aldosterone , salt and cardiac fibrosis. Clin Exp Hypert , 1997, 19: 885-899.
2Mckelvie RS, Yusuf S, Pericak D, et al. Comparison of candesartan , enalapril , and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfuntion (RESOLVD) pilot study. The RESOLVD Pilot study Investigators. Circulation, 1999, 100 : 1056-1064.
3Pitt B, Zannad F, Reme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with sever heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med , 1999,341:709-717.
4Farzin Beygui,Jean-Philippe Collet,Jean-Jacques Benoliel,Nicolas Vignolles,Raphaelle Dumaine,Olivier Barthélémy,Gilles Montalescot.High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction[J]. Circulation . 2006 (24)
5Murielle Bochud,Jürg Nussberger,Pascal Bovet,Marc R. Maillard,Robert C. Elston,Fred Paccaud,Conrad Shamlaye,Michel Burnier.Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome[J]. Hypertension . 2006 (2)
6Sookoian S, Gianotti TF, Pirola CJ. Role of the C-344T aldosterone synthase gene variant in letf ventrieular mass and left ventricular structure-related phenotypes[J]. Heart, 2008, 94(7):903-910.
7Stella P, Bigatti, G, Tizzoni L, et al. Association between aldosterone synthase (CYP1 1 B2) polymorphism and left ventricular mass in hu- man essential hypertension [J]. J Am Coll Cardiol, 2004, 43 (2): 265-270.
